⌘K

Login Start Free

Home/Filings/4/0001062993-24-008488

4//SEC Filing

Qamar Huma 4

Accession 0001062993-24-008488

CIK 0001372299other

View on SEC.gov Company Profile

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 5:41 PM ET

Size

5.3 KB

Accession

0001062993-24-008488

Insider Transaction Report

Form 4

Period: 2024-04-16

Ocugen, Inc.OCGN

Chief Medical Officer

Transactions

Award
Option (Right to Buy)
2024-04-16+308,465→ 308,465 total
Exercise: $1.59Exp: 2034-04-16→ Common Stock (308,465 underlying)

Footnotes (1)

[F1]The option vests annually in equal installments over three years commencing on April 16, 2025, subject to continued service with the Issuer on the applicable vesting dates.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Ocugen, Inc.

CIK 0001372299

Entity typeother

Related Parties

1

filerCIK 0002015296

Filing Metadata

Form type: 4
Filed: Apr 16, 8:00 PM ET
Accepted: Apr 17, 5:41 PM ET
Size: 5.3 KB

View on SEC.gov